Innoviva (INVA) Gross Profit (2011 - 2026)
Innoviva (INVA) posted Gross Profit of $75.8 million for Q1 2026, down 67.31% on a QoQ basis from $232.0 million in Q3 2025, and up 3.43% year-over-year from $73.3 million in Q1 2025.
Innoviva (INVA) Gross Profit (2011 - 2026) Analysis & Trends
Innoviva's Gross Profit history runs 9 years deep, the most recent figure standing at $75.8 million for Q1 2026.
- Quarterly Gross Profit rose 3.43% year-over-year to $75.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $464.3 million (up 6.37% YoY) and the FY2025 annual result came in at $307.7 million, up 3.87% from the prior year.
- Gross Profit was $75.8 million for Q1 2026 at Innoviva, down from $232.0 million in the prior quarter.
- Across five years, Gross Profit topped out at $261.9 million in Q3 2022 and bottomed at -$6.2 million in Q2 2023.
- A 5-year average of $101.0 million and a median of $75.8 million in 2026 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2023 — Gross Profit sank 249.76% — and 2024, when it surged 24227.13%.
- Innoviva's Gross Profit stood at $261.9 million in 2022, then retreated by 14.83% to $223.0 million in 2023, then fell by 2.22% to $218.1 million in 2024, then advanced by 6.38% to $232.0 million in 2025, then tumbled by 67.31% to $75.8 million in 2026.
- Business Quant data shows INVA's Gross Profit at $75.8 million in Q1 2026, $232.0 million in Q3 2025, and $83.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Innoviva | 1.59 Bn | 983.20 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75.83 Mn |
| Mar 31, 2026 | 75.83 Mn |
| Sep 30, 2025 | 232.00 Mn |
| Sep 30, 2025 | 232.00 Mn |
| Jun 30, 2025 | 83.15 Mn |
| Jun 30, 2025 | 83.15 Mn |
| Mar 31, 2025 | 73.32 Mn |
| Mar 31, 2025 | 73.32 Mn |
| Sep 30, 2024 | 218.08 Mn |
| Sep 30, 2024 | 218.08 Mn |
| Jun 30, 2024 | 84.99 Mn |
| Jun 30, 2024 | 84.99 Mn |
| Mar 31, 2024 | 60.09 Mn |
| Mar 31, 2024 | 60.09 Mn |
| Sep 30, 2023 | 223.02 Mn |
| Sep 30, 2023 | 223.02 Mn |
| Jun 30, 2023 | -6.15 Mn |
| Jun 30, 2023 | -6.15 Mn |
| Mar 31, 2023 | 247,000.00 |
| Mar 31, 2023 | 247,000.00 |